Bumetanide
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Pipeline Type
New Drugs in Development
Phase Of Development
Phase 1
Sponsors and Collaborators
Boston Children's Hospital, CURE
Mechanism of Action
Ion Channel
Mechanism Description
impacts Sodium/Potassium/Chloride by Inhibiting NA-K-CL transporters
Populations Tested In
Newborn Seizures
Other Resources
Special FDA Designation
Nonprofit or Government Support
Nonprofit
Nonprofit or Government Support Description
CURE: Citizens United for Research in Epilepsy; Charles H. Hood Foundation; Mooney Family Initiative for Translational Studies in Rare Diseases; National Institute of Neurological Disorders and Stroke (NINDS)
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
Boston, MA
Clinical Trial link